J64125-2_Std_Tal_L4_Final_Report.pdf
PDF 19 MB Posted
- Solicitation number
- W912DS18B0006
About this file
J64125-2 Std_Tal_L4 Final Report
View the file
Other files
Show all 17
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
ANALYTICAL REPORT
Job Number: 180-64125-2
Job Description: USACE/NYD
For:
Battelle
397 Washington Street Duxbury, MA 02332
Attention: Elisabeth Barrows
Approved for release.
Carrie L Gamber Senior Project Manager
3/30/2017 4:09 PM
Carrie L Gamber, Senior Project Manager 301 Alpha Drive, Pittsburgh, PA, 15238
(412)963-2428 carrie.gamber@testamericainc.com
03/30/2017
The test results in this report meet all NELAP requirements for parameters for which accreditation is required or available. Any exceptions to the NELAP requirements are noted in this report. Pursuant to NELAP, this report may not be reproduced, except in full, without the written approval of the laboratory. This report is confidential and is intended for the sole use of TestAmerica and its client. All questions regarding this report should be directed to the TestAmerica Project Manager or designee who has signed this report.
TestAmerica Laboratories, Inc.
TestAmerica Pittsburgh 301 Alpha Drive, RIDC Park, Pittsburgh, PA 15238
Tel (412) 963-7058 Fax (412) 963-2468 www.testamericainc.com mailto:carrie.gamber@testamericainc.com http://www.testamericainc.com http://
Table of Contents Cover Title Page
Data Summaries
Definitions
Case Narrative
Detection Summary
Client Sample Results
Default Detection Limits
Surrogate Summary
Isotope Dilution Summary
QC Sample Results
QC Association
Chronicle
Certification Summary
Method Summary
Sample Summary
Manual Integration Summary
Reagent Traceability
COAs
Organic Sample Data
Dioxin
1613B 1613B QC Summary 1613B Sample Data Standards Data
1613B ICAL Data 1613B Resolution Data
Table of Contents 1613B CCAL Data
Raw QC Data 1613B Tune Data 1613B Blank Data 1613B LCS/LCSD Data 1613B MS/MSD Data
1613B Run Logs 1613B Prep Data
Subcontracted Data
Shipping and Receiving Documents
Client Chain of Custody
Sample Receipt Checklist
Definitions/Glossary TestAmerica Job ID: 180-64125-2Client: Battelle
Project/Site: USACE/NYD
Qualifiers
Dioxin
Qualifier Description
B Compound was found in the blank and sample.
Qualifier
J Result is less than the RL but greater than or equal to the MDL and the concentration is an approximate value.
q The reported result is the estimated maximum possible concentration of this analyte, quantitated using the theoretical ion ratio. The measured ion ratio does not meet qualitative identification criteria and indicates a possible interference.
U Indicates the analyte was analyzed for but not detected.
Glossary
These commonly used abbreviations may or may not be present in this report.
¤ Listed under the "D" column to designate that the result is reported on a dry weight basis
Abbreviation
%R Percent Recovery
CFL Contains Free Liquid
CNF Contains no Free Liquid
DER Duplicate error ratio (normalized absolute difference)
Dil Fac Dilution Factor
DL, RA, RE, IN Indicates a Dilution, Re-analysis, Re-extraction, or additional Initial metals/anion analysis of the sample
DLC Decision level concentration
MDA Minimum detectable activity
EDL Estimated Detection Limit
MDC Minimum detectable concentration
MDL Method Detection Limit
ML Minimum Level (Dioxin)
NC Not Calculated
ND Not detected at the reporting limit (or MDL or EDL if shown)
PQL Practical Quantitation Limit
QC Quality Control
RER Relative error ratio
RL Reporting Limit or Requested Limit (Radiochemistry)
RPD Relative Percent Difference, a measure of the relative difference between two points
TEF Toxicity Equivalent Factor (Dioxin)
TEQ Toxicity Equivalent Quotient (Dioxin)
TestAmerica Pittsburgh
CASE NARRATIVE
Client: Battelle
Project: USACE/NYD
Report Number: 180-64125-2
With the exceptions noted as flags or footnotes, standard analytical protocols were followed in the analysis of the samples and no problems were encountered or anomalies observed. In addition all laboratory quality control samples were within established control limits, with any exceptions noted below. Each sample was analyzed to achieve the lowest possible reporting limit within the constraints of the method. In some cases, due to interference or analytes present at high concentrations, samples were diluted. For diluted samples, the reporting limits are adjusted relative to the dilution required.
Calculations are performed before rounding to avoid round-off errors in calculated results.
All holding times were met and proper preservation noted for the methods performed on these samples, unless otherwise detailed in the individual sections below.
RECEIPT
The samples were received on 03/08/2017; the samples arrived in good condition, properly preserved and on ice. The temperature of the coolers at receipt was 2.0 C.
DIOXINS
Several analytes were detected in method blank LB 140-9701/5-A at levels that were above the method detection limit but below the reporting limit. The values should be considered estimates, and have been flagged. If the associated sample reported a result above the MDL and/or RL, the result has been flagged.
Several analytes were detected in method blank MB 140-9701/6-A at levels that were above the method detection limit but below the reporting limit. The values should be considered estimates, and have been flagged. If the associated sample reported a result above the MDL and/or RL, the result has been flagged.
Detection Summary
Project/Site: USACE/NYD
Client Sample ID: #20170156 AMENDED COMPOSITE J Lab Sample ID: 180-64125-3
1,2,3,4,7,8-HxCDD
RL
48 pg/L
EDL
0.36
Analyte Result Qualifier Unit Dil Fac D Method Prep Type
SPLP East1J B q1.1 1613B
1,2,3,7,8,9-HxCDD 48 pg/L0.34 SPLP East11.2 J B 1613B
1,2,3,4,6,7,8-HpCDD 48 pg/L0.64 SPLP East12.3 J B 1613B
OCDD 96 pg/L0.30 SPLP East18.3 J B 1613B
2,3,4,7,8-PeCDF 48 pg/L0.30 SPLP East10.49 J B q 1613B
1,2,3,4,7,8-HxCDF 48 pg/L0.28 SPLP East10.83 J q 1613B
1,2,3,6,7,8-HxCDF 48 pg/L0.27 SPLP East10.94 J 1613B
2,3,4,6,7,8-HxCDF 48 pg/L0.30 SPLP East11.0 J B q 1613B
1,2,3,7,8,9-HxCDF 48 pg/L0.44 SPLP East10.96 J B q 1613B
1,2,3,4,6,7,8-HpCDF 48 pg/L0.18 SPLP East11.5 J B 1613B
1,2,3,4,7,8,9-HpCDF 48 pg/L0.28 SPLP East11.3 J B q 1613B
OCDF 96 pg/L0.28 SPLP East16.1 J B 1613B
Client Sample ID: #20170167 AMENDED COMPOSITE U Lab Sample ID: 180-64125-4
1,2,3,7,8,9-HxCDD
RL
48 pg/L
EDL
0.33
Analyte Result Qualifier Unit Dil Fac D Method Prep Type
SPLP East1J q B0.75 1613B
OCDD 96 pg/L0.57 SPLP East15.4 J q B 1613B
1,2,3,4,6,7,8-HpCDF 48 pg/L0.18 SPLP East10.77 J q B 1613B
1,2,3,4,7,8,9-HpCDF 48 pg/L0.26 SPLP East10.37 J q B 1613B
OCDF 96 pg/L0.26 SPLP East14.9 J q B 1613B
TestAmerica Pittsburgh
This Detection Summary does not include radiochemical test results.
Client Sample Results
Project/Site: USACE/NYD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) - SPLP East
Lab Sample ID: 180-64125-3Client Sample ID: #20170156 AMENDED COMPOSITE J Matrix: SedimentDate Collected: 03/03/17 09:45
Date Received: 03/08/17 09:15
RL EDL
2,3,7,8-TCDD 9.6 U 9.6 0.75 pg/L 03/21/17 14:50 03/23/17 03:29 1
Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier
48 0.65 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,7,8-PeCDD 48 U
48 0.36 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,4,7,8-HxCDD 1.1 J B q
48 0.37 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,6,7,8-HxCDD 48 U
48 0.34 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,7,8,9-HxCDD 1.2 J B
48 0.64 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,4,6,7,8-HpCDD 2.3 J B
96 0.30 pg/L 03/21/17 14:50 03/23/17 03:29 1OCDD 8.3 J B
9.6 0.52 pg/L 03/21/17 14:50 03/23/17 03:29 12,3,7,8-TCDF 9.6 U
48 0.30 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,7,8-PeCDF 48 U
48 0.30 pg/L 03/21/17 14:50 03/23/17 03:29 12,3,4,7,8-PeCDF 0.49 J B q
48 0.28 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,4,7,8-HxCDF 0.83 J q
48 0.27 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,6,7,8-HxCDF 0.94 J
48 0.30 pg/L 03/21/17 14:50 03/23/17 03:29 12,3,4,6,7,8-HxCDF 1.0 J B q
48 0.44 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,7,8,9-HxCDF 0.96 J B q
48 0.18 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,4,6,7,8-HpCDF 1.5 J B
48 0.28 pg/L 03/21/17 14:50 03/23/17 03:29 11,2,3,4,7,8,9-HpCDF 1.3 J B q
96 0.28 pg/L 03/21/17 14:50 03/23/17 03:29 1OCDF 6.1 J B
13C-2,3,7,8-TCDD 64 25 - 164 03/21/17 14:50 03/23/17 03:29 1
Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery
13C-1,2,3,7,8-PeCDD 62 03/21/17 14:50 03/23/17 03:29 125 - 181
13C-1,2,3,4,7,8-HxCDD 79 03/21/17 14:50 03/23/17 03:29 132 - 141
13C-1,2,3,6,7,8-HxCDD 75 03/21/17 14:50 03/23/17 03:29 128 - 130
13C-1,2,3,4,6,7,8-HpCDD 66 03/21/17 14:50 03/23/17 03:29 123 - 140
13C-OCDD 49 03/21/17 14:50 03/23/17 03:29 117 - 157
13C-2,3,7,8-TCDF 68 03/21/17 14:50 03/23/17 03:29 124 - 169
13C-1,2,3,7,8-PeCDF 67 03/21/17 14:50 03/23/17 03:29 124 - 185
13C-2,3,4,7,8-PeCDF 63 03/21/17 14:50 03/23/17 03:29 121 - 178
13C-1,2,3,4,7,8-HxCDF 80 03/21/17 14:50 03/23/17 03:29 126 - 152
13C-1,2,3,6,7,8-HxCDF 78 03/21/17 14:50 03/23/17 03:29 126 - 123
13C-2,3,4,6,7,8-HxCDF 79 03/21/17 14:50 03/23/17 03:29 128 - 136
13C-1,2,3,7,8,9-HxCDF 67 03/21/17 14:50 03/23/17 03:29 129 - 147
13C-1,2,3,4,6,7,8-HpCDF 69 03/21/17 14:50 03/23/17 03:29 128 - 143
13C-1,2,3,4,7,8,9-HpCDF 60 03/21/17 14:50 03/23/17 03:29 126 - 138
13C-OCDF 47 03/21/17 14:50 03/23/17 03:29 117 - 157
37Cl4-2,3,7,8-TCDD 84 35 - 197 03/21/17 14:50 03/23/17 03:29 1
Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery
Client Sample Results
Project/Site: USACE/NYD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) - SPLP East
Lab Sample ID: 180-64125-4Client Sample ID: #20170167 AMENDED COMPOSITE U Matrix: SedimentDate Collected: 03/03/17 10:15
Date Received: 03/08/17 09:15
RL EDL
2,3,7,8-TCDD 9.6 U 9.6 0.72 pg/L 03/21/17 14:50 03/23/17 04:30 1
Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier
48 0.90 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,7,8-PeCDD 48 U
48 0.33 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,4,7,8-HxCDD 48 U
48 0.37 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,6,7,8-HxCDD 48 U
48 0.33 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,7,8,9-HxCDD 0.75 J q B
48 0.87 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,4,6,7,8-HpCDD 48 U
96 0.57 pg/L 03/21/17 14:50 03/23/17 04:30 1OCDD 5.4 J q B
9.6 0.70 pg/L 03/21/17 14:50 03/23/17 04:30 12,3,7,8-TCDF 9.6 U
48 0.57 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,7,8-PeCDF 48 U
48 0.54 pg/L 03/21/17 14:50 03/23/17 04:30 12,3,4,7,8-PeCDF 48 U
48 0.30 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,4,7,8-HxCDF 48 U
48 0.28 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,6,7,8-HxCDF 48 U
48 0.33 pg/L 03/21/17 14:50 03/23/17 04:30 12,3,4,6,7,8-HxCDF 48 U
48 0.45 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,7,8,9-HxCDF 48 U
48 0.18 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,4,6,7,8-HpCDF 0.77 J q B
48 0.26 pg/L 03/21/17 14:50 03/23/17 04:30 11,2,3,4,7,8,9-HpCDF 0.37 J q B
96 0.26 pg/L 03/21/17 14:50 03/23/17 04:30 1OCDF 4.9 J q B
13C-2,3,7,8-TCDD 68 25 - 164 03/21/17 14:50 03/23/17 04:30 1
Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery
13C-1,2,3,7,8-PeCDD 63 03/21/17 14:50 03/23/17 04:30 125 - 181
13C-1,2,3,4,7,8-HxCDD 79 03/21/17 14:50 03/23/17 04:30 132 - 141
13C-1,2,3,6,7,8-HxCDD 75 03/21/17 14:50 03/23/17 04:30 128 - 130
13C-1,2,3,4,6,7,8-HpCDD 71 03/21/17 14:50 03/23/17 04:30 123 - 140
13C-OCDD 55 03/21/17 14:50 03/23/17 04:30 117 - 157
13C-2,3,7,8-TCDF 69 03/21/17 14:50 03/23/17 04:30 124 - 169
13C-1,2,3,7,8-PeCDF 67 03/21/17 14:50 03/23/17 04:30 124 - 185
13C-2,3,4,7,8-PeCDF 65 03/21/17 14:50 03/23/17 04:30 121 - 178
13C-1,2,3,4,7,8-HxCDF 85 03/21/17 14:50 03/23/17 04:30 126 - 152
13C-1,2,3,6,7,8-HxCDF 84 03/21/17 14:50 03/23/17 04:30 126 - 123
13C-2,3,4,6,7,8-HxCDF 82 03/21/17 14:50 03/23/17 04:30 128 - 136
13C-1,2,3,7,8,9-HxCDF 72 03/21/17 14:50 03/23/17 04:30 129 - 147
13C-1,2,3,4,6,7,8-HpCDF 72 03/21/17 14:50 03/23/17 04:30 128 - 143
13C-1,2,3,4,7,8,9-HpCDF 65 03/21/17 14:50 03/23/17 04:30 126 - 138
13C-OCDF 52 03/21/17 14:50 03/23/17 04:30 117 - 157
37Cl4-2,3,7,8-TCDD 83 35 - 197 03/21/17 14:50 03/23/17 04:30 1
Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery
Default Detection Limits Client: Battelle TestAmerica Job ID: 180-64125-2 Project/Site: USACE/NYD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) - SPLP East Prep: HRMS-Sepf
501,2,3,4,6,7,8-HpCDD pg/L
Analyte Units MethodRL
1613B
501,2,3,4,6,7,8-HpCDF pg/L 1613B
501,2,3,4,7,8,9-HpCDF pg/L 1613B
501,2,3,4,7,8-HxCDD pg/L 1613B
501,2,3,4,7,8-HxCDF pg/L 1613B
501,2,3,6,7,8-HxCDD pg/L 1613B
501,2,3,6,7,8-HxCDF pg/L 1613B
501,2,3,7,8,9-HxCDD pg/L 1613B
501,2,3,7,8,9-HxCDF pg/L 1613B
501,2,3,7,8-PeCDD pg/L 1613B
501,2,3,7,8-PeCDF pg/L 1613B
502,3,4,6,7,8-HxCDF pg/L 1613B
502,3,4,7,8-PeCDF pg/L 1613B
102,3,7,8-TCDD pg/L 1613B
102,3,7,8-TCDF pg/L 1613B
100OCDD pg/L 1613B
100OCDF pg/L 1613B
Surrogate Summary
Project/Site: USACE/NYD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) Prep Type: Total/NAMatrix: Sediment
Lab Sample ID Client Sample ID (35-197)
37TCDD
77LB 140-9701/5-A
Percent Surrogate Recovery (Acceptance Limits)
Method Blank
85MB 140-9701/6-A Method Blank
Surrogate Legend
37TCDD = 37Cl4-2,3,7,8-TCDD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) Prep Type: Total/NAMatrix: Sediment
Lab Sample ID Client Sample ID (31-191)
37TCDD
86LCS 140-9701/7-A
Percent Surrogate Recovery (Acceptance Limits)
Lab Control Sample
Surrogate Legend
37TCDD = 37Cl4-2,3,7,8-TCDD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) Prep Type: SPLP EastMatrix: Sediment
Lab Sample ID Client Sample ID (35-197)
37TCDD
84180-64125-3
Percent Surrogate Recovery (Acceptance Limits)
#20170156 AMENDED COMPOSITE J
83180-64125-4 #20170167 AMENDED COMPOSITE U
89180-64125-4 MS #20170167 AMENDED COMPOSITE U
84180-64125-4 MSD #20170167 AMENDED COMPOSITE U
Surrogate Legend
37TCDD = 37Cl4-2,3,7,8-TCDD
Isotope Dilution Summary
Project/Site: USACE/NYD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) Prep Type: Total/NAMatrix: Sediment
Lab Sample ID Client Sample ID (25-164) (25-181) (32-141) (28-130) (23-140) (17-157) (24-169) (24-185)
TCDD PeCDD HxCDD1 HxCDD2 HpCDD OCDD TCDF PeCDF1
71 68 84 83 73 56 71 73LB 140-9701/5-A
Percent Isotope Dilution Recovery (Acceptance Limits)
Method Blank
74 76 96 7694 60 79 77MB 140-9701/6-A Method Blank
Lab Sample ID Client Sample ID (21-178) (26-152) (26-123) (28-136) (29-147) (28-143) (26-138) (17-157)
PeCDF2 HxCDF1 HxCDF2 HxCDF3 HxCDF4 HpCDF1 HpCDF2 13C-OCDF
69 93 85 88 75 76 65 51LB 140-9701/5-A
Percent Isotope Dilution Recovery (Acceptance Limits)
Method Blank
79 100 94 8194 80 67 56MB 140-9701/6-A Method Blank
Surrogate Legend
TCDD = 13C-2,3,7,8-TCDD
PeCDD = 13C-1,2,3,7,8-PeCDD
HxCDD1 = 13C-1,2,3,4,7,8-HxCDD
HxCDD2 = 13C-1,2,3,6,7,8-HxCDD
HpCDD = 13C-1,2,3,4,6,7,8-HpCDD
OCDD = 13C-OCDD
TCDF = 13C-2,3,7,8-TCDF
PeCDF1 = 13C-1,2,3,7,8-PeCDF
PeCDF2 = 13C-2,3,4,7,8-PeCDF
HxCDF1 = 13C-1,2,3,4,7,8-HxCDF
HxCDF2 = 13C-1,2,3,6,7,8-HxCDF
HxCDF3 = 13C-2,3,4,6,7,8-HxCDF
HxCDF4 = 13C-1,2,3,7,8,9-HxCDF
HpCDF1 = 13C-1,2,3,4,6,7,8-HpCDF
HpCDF2 = 13C-1,2,3,4,7,8,9-HpCDF
13C-OCDF = 13C-OCDF
Method: 1613B - Dioxins and Furans (HRGC/HRMS) Prep Type: Total/NAMatrix: Sediment
Lab Sample ID Client Sample ID (20-175) (21-227) (21-193) (25-163) (26-166) (13-199) (22-152) (21-192)
TCDD PeCDD HxCDD1 HxCDD2 HpCDD OCDD TCDF PeCDF1
76 78 90 89 76 60 80 80LCS 140-9701/7-A
Percent Isotope Dilution Recovery (Acceptance Limits)
Lab Control Sample
Lab Sample ID Client Sample ID (13-328) (19-202) (21-159) (22-176) (17-205) (21-158) (20-186) (13-199)
PeCDF2 HxCDF1 HxCDF2 HxCDF3 HxCDF4 HpCDF1 HpCDF2 13C-OCDF
79 98 90 94 77 82 68 57LCS 140-9701/7-A
Percent Isotope Dilution Recovery (Acceptance Limits)
Lab Control Sample
Surrogate Legend
TCDD = 13C-2,3,7,8-TCDD
PeCDD = 13C-1,2,3,7,8-PeCDD
HxCDD1 = 13C-1,2,3,4,7,8-HxCDD
HxCDD2 = 13C-1,2,3,6,7,8-HxCDD
HpCDD = 13C-1,2,3,4,6,7,8-HpCDD
OCDD = 13C-OCDD
TCDF = 13C-2,3,7,8-TCDF
PeCDF1 = 13C-1,2,3,7,8-PeCDF
PeCDF2 = 13C-2,3,4,7,8-PeCDF
HxCDF1 = 13C-1,2,3,4,7,8-HxCDF
Isotope Dilution Summary
Project/Site: USACE/NYD
HxCDF2 = 13C-1,2,3,6,7,8-HxCDF
HxCDF3 = 13C-2,3,4,6,7,8-HxCDF
HxCDF4 = 13C-1,2,3,7,8,9-HxCDF
HpCDF1 = 13C-1,2,3,4,6,7,8-HpCDF
HpCDF2 = 13C-1,2,3,4,7,8,9-HpCDF
13C-OCDF = 13C-OCDF
Method: 1613B - Dioxins and Furans (HRGC/HRMS) Prep Type: SPLP EastMatrix: Sediment
Lab Sample ID Client Sample ID (25-164) (25-181) (32-141) (28-130) (23-140) (17-157) (24-169) (24-185)
TCDD PeCDD HxCDD1 HxCDD2 HpCDD OCDD TCDF PeCDF1
64 62 79 75 66 49 68 67180-64125-3
Percent Isotope Dilution Recovery (Acceptance Limits)
#20170156 AMENDED COMPOSITE J
68 63 79 7175 55 69 67180-64125-4 #20170167 AMENDED COMPOSITE U
69 69 82 7379 60 75 73180-64125-4 MS #20170167 AMENDED COMPOSITE U
66 65 78 6879 56 71 69180-64125-4 MSD #20170167 AMENDED COMPOSITE U
Lab Sample ID Client Sample ID (21-178) (26-152) (26-123) (28-136) (29-147) (28-143) (26-138) (17-157)
PeCDF2 HxCDF1 HxCDF2 HxCDF3 HxCDF4 HpCDF1 HpCDF2 13C-OCDF
63 80 78 79 67 69 60 47180-64125-3
Percent Isotope Dilution Recovery (Acceptance Limits)
#20170156 AMENDED COMPOSITE J
65 85 84 7282 72 65 52180-64125-4 #20170167 AMENDED COMPOSITE U
72 90 85 7483 77 70 57180-64125-4 MS #20170167 AMENDED COMPOSITE U
69 86 80 7078 72 61 52180-64125-4 MSD #20170167 AMENDED COMPOSITE U
Surrogate Legend
TCDD = 13C-2,3,7,8-TCDD
PeCDD = 13C-1,2,3,7,8-PeCDD
HxCDD1 = 13C-1,2,3,4,7,8-HxCDD
HxCDD2 = 13C-1,2,3,6,7,8-HxCDD
HpCDD = 13C-1,2,3,4,6,7,8-HpCDD
OCDD = 13C-OCDD
TCDF = 13C-2,3,7,8-TCDF
PeCDF1 = 13C-1,2,3,7,8-PeCDF
PeCDF2 = 13C-2,3,4,7,8-PeCDF
HxCDF1 = 13C-1,2,3,4,7,8-HxCDF
HxCDF2 = 13C-1,2,3,6,7,8-HxCDF
HxCDF3 = 13C-2,3,4,6,7,8-HxCDF
HxCDF4 = 13C-1,2,3,7,8,9-HxCDF
HpCDF1 = 13C-1,2,3,4,6,7,8-HpCDF
HpCDF2 = 13C-1,2,3,4,7,8,9-HpCDF
13C-OCDF = 13C-OCDF
QC Sample Results
Project/Site: USACE/NYD
Method: 1613B - Dioxins and Furans (HRGC/HRMS)
Client Sample ID: Method BlankLab Sample ID: LB 140-9701/5-A Matrix: Sediment Prep Type: Total/NA Analysis Batch: 9766 Prep Batch: 9701
RL EDL
2,3,7,8-TCDD 9.7 U 9.7 0.67 pg/L 03/21/17 14:50 03/23/17 02:28 1
LB LB
Analyte Dil FacAnalyzedPreparedDUnitResult Qualifier
1.06 J q 0.1448 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,7,8-PeCDD
1.61 J 0.1948 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,4,7,8-HxCDD
0.695 J q 0.1948 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,6,7,8-HxCDD
1.88 J 0.1848 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,7,8,9-HxCDD
3.51 J q 0.9548 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,4,6,7,8-HpCDD
9.21 J q 0.4397 pg/L 03/21/17 14:50 03/23/17 02:28 1OCDD
9.7 U 0.529.7 pg/L 03/21/17 14:50 03/23/17 02:28 12,3,7,8-TCDF
0.650 J q 0.3748 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,7,8-PeCDF
0.840 J q 0.3748 pg/L 03/21/17 14:50 03/23/17 02:28 12,3,4,7,8-PeCDF
48 U 0.6848 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,4,7,8-HxCDF
48 U 0.6748 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,6,7,8-HxCDF
48 U 0.7448 pg/L 03/21/17 14:50 03/23/17 02:28 12,3,4,6,7,8-HxCDF
48 U 1.148 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,7,8,9-HxCDF
2.80 J q 0.2348 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,4,6,7,8-HpCDF
2.49 J 0.3848 pg/L 03/21/17 14:50 03/23/17 02:28 11,2,3,4,7,8,9-HpCDF
9.14 J 0.3897 pg/L 03/21/17 14:50 03/23/17 02:28 1OCDF
13C-2,3,7,8-TCDD 71 25 - 164 03/23/17 02:28 1
LB LB
Isotope Dilution
03/21/17 14:50
Dil FacPrepared AnalyzedQualifier Limits%Recovery
68 03/21/17 14:50 03/23/17 02:28 113C-1,2,3,7,8-PeCDD 25 - 181
84 03/21/17 14:50 03/23/17 02:28 113C-1,2,3,4,7,8-HxCDD 32 - 141
83 03/21/17 14:50 03/23/17 02:28 113C-1,2,3,6,7,8-HxCDD 28 - 130
73 03/21/17 14:50 03/23/17 02:28 113C-1,2,3,4,6,7,8-HpCDD 23 - 140
56 03/21/17 14:50 03/23/17 02:28 113C-OCDD 17 - 157
71 03/21/17 14:50 03/23/17 02:28 113C-2,3,7,8-TCDF 24 - 169
73 03/21/17 14:50 03/23/17 02:28 113C-1,2,3,7,8-PeCDF 24 - 185
69 03/21/17 14:50 03/23/17 02:28 113C-2,3,4,7,8-PeCDF 21 - 178
93 03/21/17 14:50 03/23/17 02:28 113C-1,2,3,4,7,8-HxCDF 26 - 152
85 03/21/17 14:50 03/23/17 02:28 113C-1,2,3,6,7,8-HxCDF 26 - 123
88 03/21/17 14:50 03/23/17 02:28 113C-2,3,4,6,7,8-HxCDF 28 - 136
75 03/21/17 14:50 03/23/17 02:28 113C-1,2,3,7,8,9-HxCDF 29 - 147
76 03/21/17 14:50 03/23/17 02:28 113C-1,2,3,4,6,7,8-HpCDF 28 - 143
65 03/21/17 14:50 03/23/17 02:28 113C-1,2,3,4,7,8,9-HpCDF 26 - 138
51 03/21/17 14:50 03/23/17 02:28 113C-OCDF 17 - 157
37Cl4-2,3,7,8-TCDD 77 35 - 197 03/23/17 02:28 1
LB LB
Surrogate
03/21/17 14:50
Dil FacPrepared AnalyzedQualifier Limits%Recovery
Client Sample ID: Method BlankLab Sample ID: MB 140-9701/6-A Matrix: Sediment Prep Type: Total/NA Analysis Batch: 9766 Prep Batch: 9701
RL EDL
2,3,7,8-TCDD 10 U 10 0.76 pg/L 03/21/17 14:50 03/23/17 01:27 1
MB MB
Analyte Dil FacAnalyzedPreparedDUnitResult Qualifier
1.41 J q 0.6350 pg/L 03/21/17 14:50 03/23/17 01:27 11,2,3,7,8-PeCDD
3.11 J 0.4150 pg/L 03/21/17 14:50 03/23/17 01:27 11,2,3,4,7,8-HxCDD
1.97 J q 0.4250 pg/L 03/21/17 14:50 03/23/17 01:27 11,2,3,6,7,8-HxCDD
Project/Site: USACE/NYD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) (Continued)
Client Sample ID: Method BlankLab Sample ID: MB 140-9701/6-A Matrix: Sediment Prep Type: Total/NA Analysis Batch: 9766 Prep Batch: 9701
RL EDL
1,2,3,7,8,9-HxCDD 2.82 J 50 0.39 pg/L 03/21/17 14:50 03/23/17 01:27 1
MB MB
Analyte Dil FacAnalyzedPreparedDUnitResult Qualifier
4.70 J q 1.150 pg/L 03/21/17 14:50 03/23/17 01:27 11,2,3,4,6,7,8-HpCDD
20.9 J 0.57100 pg/L 03/21/17 14:50 03/23/17 01:27 1OCDD
10 U 0.5210 pg/L 03/21/17 14:50 03/23/17 01:27 12,3,7,8-TCDF
1.15 J q 0.5750 pg/L 03/21/17 14:50 03/23/17 01:27 11,2,3,7,8-PeCDF
50 U 0.5250 pg/L 03/21/17 14:50 03/23/17 01:27 12,3,4,7,8-PeCDF
50 U 1.250 pg/L 03/21/17 14:50 03/23/17 01:27 11,2,3,4,7,8-HxCDF
50 U 1.250 pg/L 03/21/17 14:50 03/23/17 01:27 11,2,3,6,7,8-HxCDF
2.88 J 1.350 pg/L 03/21/17 14:50 03/23/17 01:27 12,3,4,6,7,8-HxCDF
2.58 J q 1.850 pg/L 03/21/17 14:50 03/23/17 01:27 11,2,3,7,8,9-HxCDF
5.82 J 0.3150 pg/L 03/21/17 14:50 03/23/17 01:27 11,2,3,4,6,7,8-HpCDF
6.13 J 0.5050 pg/L 03/21/17 14:50 03/23/17 01:27 11,2,3,4,7,8,9-HpCDF
14.8 J 0.41100 pg/L 03/21/17 14:50 03/23/17 01:27 1OCDF
13C-2,3,7,8-TCDD 74 25 - 164 03/23/17 01:27 1
MB MB
Isotope Dilution
03/21/17 14:50
Dil FacPrepared AnalyzedQualifier Limits%Recovery
76 03/21/17 14:50 03/23/17 01:27 113C-1,2,3,7,8-PeCDD 25 - 181
96 03/21/17 14:50 03/23/17 01:27 113C-1,2,3,4,7,8-HxCDD 32 - 141
94 03/21/17 14:50 03/23/17 01:27 113C-1,2,3,6,7,8-HxCDD 28 - 130
76 03/21/17 14:50 03/23/17 01:27 113C-1,2,3,4,6,7,8-HpCDD 23 - 140
60 03/21/17 14:50 03/23/17 01:27 113C-OCDD 17 - 157
79 03/21/17 14:50 03/23/17 01:27 113C-2,3,7,8-TCDF 24 - 169
77 03/21/17 14:50 03/23/17 01:27 113C-1,2,3,7,8-PeCDF 24 - 185
79 03/21/17 14:50 03/23/17 01:27 113C-2,3,4,7,8-PeCDF 21 - 178
100 03/21/17 14:50 03/23/17 01:27 113C-1,2,3,4,7,8-HxCDF 26 - 152
94 03/21/17 14:50 03/23/17 01:27 113C-1,2,3,6,7,8-HxCDF 26 - 123
94 03/21/17 14:50 03/23/17 01:27 113C-2,3,4,6,7,8-HxCDF 28 - 136
81 03/21/17 14:50 03/23/17 01:27 113C-1,2,3,7,8,9-HxCDF 29 - 147
80 03/21/17 14:50 03/23/17 01:27 113C-1,2,3,4,6,7,8-HpCDF 28 - 143
67 03/21/17 14:50 03/23/17 01:27 113C-1,2,3,4,7,8,9-HpCDF 26 - 138
56 03/21/17 14:50 03/23/17 01:27 113C-OCDF 17 - 157
37Cl4-2,3,7,8-TCDD 85 35 - 197 03/23/17 01:27 1
MB MB
Surrogate
03/21/17 14:50
Dil FacPrepared AnalyzedQualifier Limits%Recovery
Client Sample ID: Lab Control SampleLab Sample ID: LCS 140-9701/7-A Matrix: Sediment Prep Type: Total/NA Analysis Batch: 9766 Prep Batch: 9701
2,3,7,8-TCDD 200 200 pg/L 100 67 - 158
Analyte
LCS LCS
DUnitResult Qualifier %Rec
Spike
Added
%Rec.
Limits
1,2,3,7,8-PeCDD 1000 986 pg/L 99 70 - 142
1,2,3,4,7,8-HxCDD 1000 983 pg/L 98 70 - 164
1,2,3,6,7,8-HxCDD 1000 947 pg/L 95 76 - 134
1,2,3,7,8,9-HxCDD 1000 955 pg/L 95 64 - 162
1,2,3,4,6,7,8-HpCDD 1000 931 pg/L 93 70 - 140
OCDD 2000 1790 pg/L 90 78 - 144
2,3,7,8-TCDF 200 200 pg/L 100 75 - 158
Project/Site: USACE/NYD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) (Continued)
Client Sample ID: Lab Control SampleLab Sample ID: LCS 140-9701/7-A Matrix: Sediment Prep Type: Total/NA Analysis Batch: 9766 Prep Batch: 9701
1,2,3,7,8-PeCDF 1000 905 pg/L 91 80 - 134
Analyte
LCS LCS
DUnitResult Qualifier %Rec
Spike
Added
%Rec.
Limits
2,3,4,7,8-PeCDF 1000 976 pg/L 98 68 - 160
1,2,3,4,7,8-HxCDF 1000 949 pg/L 95 72 - 134
1,2,3,6,7,8-HxCDF 1000 957 pg/L 96 84 - 130
2,3,4,6,7,8-HxCDF 1000 917 pg/L 92 70 - 156
1,2,3,7,8,9-HxCDF 1000 952 pg/L 95 78 - 130
1,2,3,4,6,7,8-HpCDF 1000 930 pg/L 93 82 - 122
1,2,3,4,7,8,9-HpCDF 1000 966 pg/L 97 78 - 138
OCDF 2000 1800 pg/L 90 63 - 170
13C-2,3,7,8-TCDD 20 - 175
Isotope Dilution
LCS LCS
Qualifier Limits%Recovery
7813C-1,2,3,7,8-PeCDD 21 - 227
9013C-1,2,3,4,7,8-HxCDD 21 - 193
8913C-1,2,3,6,7,8-HxCDD 25 - 163
7613C-1,2,3,4,6,7,8-HpCDD 26 - 166
6013C-OCDD 13 - 199
8013C-2,3,7,8-TCDF 22 - 152
8013C-1,2,3,7,8-PeCDF 21 - 192
7913C-2,3,4,7,8-PeCDF 13 - 328
9813C-1,2,3,4,7,8-HxCDF 19 - 202
9013C-1,2,3,6,7,8-HxCDF 21 - 159
9413C-2,3,4,6,7,8-HxCDF 22 - 176
7713C-1,2,3,7,8,9-HxCDF 17 - 205
8213C-1,2,3,4,6,7,8-HpCDF 21 - 158
6813C-1,2,3,4,7,8,9-HpCDF 20 - 186
5713C-OCDF 13 - 199
37Cl4-2,3,7,8-TCDD 31 - 191
Surrogate
LCS LCS
Qualifier Limits%Recovery
Client Sample ID: #20170167 AMENDED COMPOSITE ULab Sample ID: 180-64125-4 MS Matrix: Sediment Prep Type: SPLP East Analysis Batch: 9786 Prep Batch: 9701
2,3,7,8-TCDD 9.6 U 192 199 pg/L 104 67 - 158
Analyte
MS MS
DUnitResult Qualifier %Rec
Spike
Added
Sample
Result
Sample
Qualifier
%Rec.
Limits
1,2,3,7,8-PeCDD 48 U 958 985 pg/L 103 70 - 142
1,2,3,4,7,8-HxCDD 48 U 958 949 pg/L 99 70 - 164
1,2,3,6,7,8-HxCDD 48 U 958 920 pg/L 96 76 - 134
1,2,3,7,8,9-HxCDD 0.75 J q B 958 961 pg/L 100 64 - 162
1,2,3,4,6,7,8-HpCDD 48 U 958 889 pg/L 93 70 - 140
OCDD 5.4 J q B 1920 1760 pg/L 91 78 - 144
2,3,7,8-TCDF 9.6 U 192 201 pg/L 105 75 - 158
1,2,3,7,8-PeCDF 48 U 958 902 pg/L 94 80 - 134
2,3,4,7,8-PeCDF 48 U 958 962 pg/L 101 68 - 160
1,2,3,4,7,8-HxCDF 48 U 958 949 pg/L 99 72 - 134
1,2,3,6,7,8-HxCDF 48 U 958 940 pg/L 98 84 - 130
Project/Site: USACE/NYD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) (Continued)
Client Sample ID: #20170167 AMENDED COMPOSITE ULab Sample ID: 180-64125-4 MS Matrix: Sediment Prep Type: SPLP East Analysis Batch: 9786 Prep Batch: 9701
2,3,4,6,7,8-HxCDF 48 U 958 953 pg/L 100 70 - 156
Analyte
MS MS
DUnitResult Qualifier %Rec
Spike
Added
Sample
Result
Sample
Qualifier
%Rec.
Limits
1,2,3,7,8,9-HxCDF 48 U 958 945 pg/L 99 78 - 130
1,2,3,4,6,7,8-HpCDF 0.77 J q B 958 951 pg/L 99 82 - 122
1,2,3,4,7,8,9-HpCDF 0.37 J q B 958 928 pg/L 97 78 - 138
OCDF 4.9 J q B 1920 1740 pg/L 91 63 - 170
13C-2,3,7,8-TCDD 25 - 164
Isotope Dilution
MS MS
Qualifier Limits%Recovery
6913C-1,2,3,7,8-PeCDD 25 - 181
8213C-1,2,3,4,7,8-HxCDD 32 - 141
7913C-1,2,3,6,7,8-HxCDD 28 - 130
7313C-1,2,3,4,6,7,8-HpCDD 23 - 140
6013C-OCDD 17 - 157
7513C-2,3,7,8-TCDF 24 - 169
7313C-1,2,3,7,8-PeCDF 24 - 185
7213C-2,3,4,7,8-PeCDF 21 - 178
9013C-1,2,3,4,7,8-HxCDF 26 - 152
8513C-1,2,3,6,7,8-HxCDF 26 - 123
8313C-2,3,4,6,7,8-HxCDF 28 - 136
7413C-1,2,3,7,8,9-HxCDF 29 - 147
7713C-1,2,3,4,6,7,8-HpCDF 28 - 143
7013C-1,2,3,4,7,8,9-HpCDF 26 - 138
5713C-OCDF 17 - 157
37Cl4-2,3,7,8-TCDD 35 - 197
Surrogate
MS MS
Qualifier Limits%Recovery
Client Sample ID: #20170167 AMENDED COMPOSITE ULab Sample ID: 180-64125-4 MSD Matrix: Sediment Prep Type: SPLP East Analysis Batch: 9766 Prep Batch: 9701
2,3,7,8-TCDD 9.6 U 193 197 pg/L 102 67 - 158 1 25
Analyte
MSD MSD
DUnitResult Qualifier %Rec
Spike
Added
Sample
Result
Sample
Qualifier
%Rec.
Limits LimitRPD
RPD
1,2,3,7,8-PeCDD 48 U 965 962 pg/L 100 70 - 142 2 25
1,2,3,4,7,8-HxCDD 48 U 965 964 pg/L 100 70 - 164 2 25
1,2,3,6,7,8-HxCDD 48 U 965 887 pg/L 92 76 - 134 4 25
1,2,3,7,8,9-HxCDD 0.75 J q B 965 935 pg/L 97 64 - 162 3 25
1,2,3,4,6,7,8-HpCDD 48 U 965 891 pg/L 92 70 - 140 0 25
OCDD 5.4 J q B 1930 1720 pg/L 89 78 - 144 2 25
2,3,7,8-TCDF 9.6 U 193 193 pg/L 100 75 - 158 4 25
1,2,3,7,8-PeCDF 48 U 965 882 pg/L 91 80 - 134 2 25
2,3,4,7,8-PeCDF 48 U 965 953 pg/L 99 68 - 160 1 25
1,2,3,4,7,8-HxCDF 48 U 965 905 pg/L 94 72 - 134 5 25
1,2,3,6,7,8-HxCDF 48 U 965 898 pg/L 93 84 - 130 5 25
2,3,4,6,7,8-HxCDF 48 U 965 921 pg/L 95 70 - 156 3 25
1,2,3,7,8,9-HxCDF 48 U 965 911 pg/L 94 78 - 130 4 25
1,2,3,4,6,7,8-HpCDF 0.77 J q B 965 897 pg/L 93 82 - 122 6 25
1,2,3,4,7,8,9-HpCDF 0.37 J q B 965 929 pg/L 96 78 - 138 0 25
Project/Site: USACE/NYD
Method: 1613B - Dioxins and Furans (HRGC/HRMS) (Continued)
Client Sample ID: #20170167 AMENDED COMPOSITE ULab Sample ID: 180-64125-4 MSD Matrix: Sediment Prep Type: SPLP East Analysis Batch: 9766 Prep Batch: 9701
OCDF 4.9 J q B 1930 1700 pg/L 88 63 - 170 3 25
Analyte
MSD MSD
DUnitResult Qualifier %Rec
Spike
Added
Sample
Result
Sample
Qualifier
%Rec.
Limits LimitRPD
RPD
13C-2,3,7,8-TCDD 25 - 164
Isotope Dilution
MSD MSD
Qualifier Limits%Recovery
6513C-1,2,3,7,8-PeCDD 25 - 181
7813C-1,2,3,4,7,8-HxCDD 32 - 141
7913C-1,2,3,6,7,8-HxCDD 28 - 130
6813C-1,2,3,4,6,7,8-HpCDD 23 - 140
5613C-OCDD 17 - 157
7113C-2,3,7,8-TCDF 24 - 169
6913C-1,2,3,7,8-PeCDF 24 - 185
6913C-2,3,4,7,8-PeCDF 21 - 178
8613C-1,2,3,4,7,8-HxCDF 26 - 152
8013C-1,2,3,6,7,8-HxCDF 26 - 123
7813C-2,3,4,6,7,8-HxCDF 28 - 136
7013C-1,2,3,7,8,9-HxCDF 29 - 147
7213C-1,2,3,4,6,7,8-HpCDF 28 - 143
6113C-1,2,3,4,7,8,9-HpCDF 26 - 138
5213C-OCDF 17 - 157
37Cl4-2,3,7,8-TCDD 35 - 197
Surrogate
MSD MSD
Qualifier Limits%Recovery
QC Association Summary
Project/Site: USACE/NYD
Specialty Organics
Prep Batch: 9701
Lab Sample ID Client Sample ID Prep Type Matrix Method Prep Batch
Sediment HRMS-Sepf180-64125-3 #20170156 AMENDED COMPOSITE J SPLP East
Sediment HRMS-Sepf180-64125-4 #20170167 AMENDED COMPOSITE U SPLP East
Sediment HRMS-SepfLB 140-9701/5-A Method Blank Total/NA
Sediment HRMS-SepfMB 140-9701/6-A Method Blank Total/NA
Sediment HRMS-SepfLCS 140-9701/7-A Lab Control Sample Total/NA
Sediment HRMS-Sepf180-64125-4 MS #20170167 AMENDED COMPOSITE U SPLP East
Sediment HRMS-Sepf180-64125-4 MSD #20170167 AMENDED COMPOSITE U SPLP East
Analysis Batch: 9766
Lab Sample ID Client Sample ID Prep Type Matrix Method Prep Batch
Sediment 1613B 9701180-64125-3 #20170156 AMENDED COMPOSITE J SPLP East
Sediment 1613B 9701180-64125-4 #20170167 AMENDED COMPOSITE U SPLP East
Sediment 1613B 9701LB 140-9701/5-A Method Blank Total/NA
Sediment 1613B 9701MB 140-9701/6-A Method Blank Total/NA
Sediment 1613B 9701LCS 140-9701/7-A Lab Control Sample Total/NA
Sediment 1613B 9701180-64125-4 MSD #20170167 AMENDED COMPOSITE U SPLP East
Analysis Batch: 9786
Lab Sample ID Client Sample ID Prep Type Matrix Method Prep Batch
Sediment 1613B 9701180-64125-4 MS #20170167 AMENDED COMPOSITE U SPLP East
Lab Chronicle
Project/Site: USACE/NYD
Client Sample ID: #20170156 AMENDED COMPOSITE J Lab Sample ID: 180-64125-3 Matrix: SedimentDate Collected: 03/03/17 09:45
Date Received: 03/08/17 09:15
Prep HRMS-Sepf SSS03/21/17 14:50 TAL KNX9701
Type
Batch
Method
Batch
Prep Type LabAnalystRun
Prepared or Analyzed
Initial
Amount Amount
Final Batch
NumberFactor
Dil
SPLP East 1037.4 mL 20 uL
Analysis 1613B 1 9766 03/23/17 03:29 LKM TAL KNXSPLP East
D2AInstrument ID:
Client Sample ID: #20170167 AMENDED COMPOSITE U Lab Sample ID: 180-64125-4 Matrix: SedimentDate Collected: 03/03/17 10:15
Date Received: 03/08/17 09:15
Prep HRMS-Sepf SSS03/21/17 14:50 TAL KNX9701
Type
Batch
Method
Batch
Prep Type LabAnalystRun
Prepared or Analyzed
Initial
Amount Amount
Final Batch
NumberFactor
Dil
SPLP East 1040.8 mL 20 uL
Analysis 1613B 1 9766 03/23/17 04:30 LKM TAL KNXSPLP East
D2AInstrument ID:
Laboratory References:
TAL KNX = TestAmerica Knoxville, 5815 Middlebrook Pike, Knoxville, TN 37921, TEL (865)291-3000
Analyst References:
Lab: TAL KNX
Batch Type: Prep
SSS = Samuel Stockton
Batch Type: Analysis
LKM = Linda McWhirter
Certification Summary
Project/Site: USACE/NYD
Laboratory: TestAmerica Pittsburgh The certifications listed below are applicable to this report.
Authority Program EPA Region Certification ID Expiration Date
New Jersey PA0052NELAP 06-30-17
New York NELAP 2 11182 03-31-17 *
Laboratory: TestAmerica Knoxville All certifications held by this laboratory are listed. Not all certifications are applicable to this report.
Authority Program EPA Region Certification ID Expiration Date
N/AAFCEE
Arkansas DEQ State Program 6 88-0688 06-16-17
California State Program 9 2423 06-30-18
Colorado State Program 8 TN00009 02-28-18
Connecticut State Program 1 PH-0223 09-30-17
Florida NELAP 4 E87177 06-30-17
Georgia State Program 4 906 04-13-17
Hawaii State Program 9 N/A 04-13-17
Kansas NELAP 7 E-10349 10-31-17
Kentucky (DW) State Program 4 90101 12-31-17
L-A-B DoD ELAP L2311 02-13-19
Louisiana NELAP 6 83979 06-30-17
Louisiana (DW) NELAP 6 LA160005 12-31-17
Maryland State Program 3 277 03-31-18
Michigan State Program 5 9933 04-13-17
Nevada State Program 9 TN00009 07-31-17
New Jersey NELAP 2 TN001 06-30-17
New York NELAP 2 10781 03-31-17
North Carolina (DW) State Program 4 21705 07-31-17
North Carolina (WW/SW) State Program 4 64 12-31-17
Ohio VAP State Program 5 CL0059 11-22-18
Oklahoma State Program 6 9415 08-31-17
Pennsylvania NELAP 3 68-00576 12-31-17
South Carolina State Program 4 84001 06-30-17
Tennessee State Program 4 2014 04-13-17
Texas NELAP 6 T104704380-16-9 08-31-17
USDA Federal P330-13-00262 08-20-19
Utah NELAP 8 TN00009 07-31-17
Virginia NELAP 3 460176 09-14-17
Washington State Program 10 C593 01-19-18
West Virginia (DW) State Program 3 9955C 12-31-17
West Virginia DEP State Program 3 345 04-30-17
Wisconsin State Program 5 998044300 08-31-17
TestAmerica Pittsburgh
* Certification renewal pending - certification considered valid.
Method Summary
Project/Site: USACE/NYD
Method Method Description LaboratoryProtocol
40CFR136A1613B Dioxins and Furans (HRGC/HRMS) TAL KNX
Protocol References:
40CFR136A = "Methods for Organic Chemical Analysis of Municipal Industrial Wastewater", 40CFR, Part 136, Appendix A, October 26, 1984 and subsequent revisions.
Laboratory References:
TAL KNX = TestAmerica Knoxville, 5815 Middlebrook Pike, Knoxville, TN 37921, TEL (865)291-3000
Sample Summary
Project/Site: USACE/NYD
Lab Sample ID Client Sample ID ReceivedCollectedMatrix
180-64125-3 #20170156 AMENDED COMPOSITE J Sediment 03/03/17 09:45 03/08/17 09:15
180-64125-4 #20170167 AMENDED COMPOSITE U Sediment 03/03/17 10:15 03/08/17 09:15
Lab Name: Job No.:
SDG No.:
DIOXIN MANUAL INTEGRATION SUMMARY
TestAmerica Knoxville 180-64125-2
Instrument ID: Analysis Batch Number:D2A 7768
Lab Sample ID: Client Sample ID:
Date Analyzed: Lab File ID:
COMPOUND NAME RETENTION
TIME
MANUAL INTEGRATION
DATEANALYSTREASON
IC 140-7768/2
d3140516i1.d05/16/14 14:26 GC Column: RTX-5 ID: 0.32(mm)
2,3,7,8-TCDF Baseline davidsonm 01/11/17 16:1129.76 2,3,7,8-TCDD Baseline davidsonm 01/11/17 16:1131.87 1,2,3,7,8-PeCDD Shouldering davidsonm 01/11/17 16:1141.02 1,2,3,7,8,9-HxCDD Shouldering davidsonm 01/11/17 16:1145.76 1,2,3,7,8,9-HxCDF Shouldering davidsonm 01/11/17 16:1146.03 OCDD Shouldering davidsonm 01/11/17 16:1154.30
1613B
DIOXIN MANUAL INTEGRATION SUMMARY
TestAmerica Knoxville 180-64125-2
Instrument ID: Analysis Batch Number:D2A 9766
Lab Sample ID: Client Sample ID:
Date Analyzed: Lab File ID:
COMPOUND NAME RETENTION
TIME
MANUAL INTEGRATION
DATEANALYSTREASON
MB 140-9701/6-A
mb140-97016-a.d03/23/17 01:27 GC Column: RTX-5 ID: 0.32(mm)
1,2,3,7,8-PeCDF Baseline mcwhirter l
03/23/17 09:0539.15
1,2,3,7,8-PeCDD Baseline mcwhirter l
03/23/17 09:0540.87
1,2,3,7,8,9-HxCDF Split Peak davidsonm 03/23/17 09:0545.87
Lab Sample ID: Client Sample ID:
Date Analyzed: Lab File ID:
COMPOUND NAME RETENTION
TIME
MANUAL INTEGRATION
DATEANALYSTREASON
LB 140-9701/5-A
lb140-97015-a.d03/23/17 02:28 GC Column: RTX-5 ID: 0.32(mm)
1,2,3,7,8-PeCDF Baseline davidsonm 03/23/17 08:0439.17 2,3,4,7,8-PeCDF Baseline davidsonm 03/23/17 08:0440.39 1,2,3,7,8-PeCDD Split Peak davidsonm 03/23/17 08:0440.87 13C-1,2,3,4,7,8-HxCDD Split Peak davidsonm 03/23/17 08:0445.10 13C-1,2,3,6,7,8-HxCDD Split Peak davidsonm 03/23/17 08:0445.22 1,2,3,7,8,9-HxCDD Split Peak davidsonm 03/23/17 08:0445.61 1,2,3,4,6,7,8-HpCDF Baseline davidsonm 03/23/17 08:0448.29 1,2,3,4,6,7,8-HpCDD Baseline davidsonm 03/23/17 08:0450.00 1,2,3,4,7,8,9-HpCDF Split Peak davidsonm 03/23/17 08:0450.64 OCDD Split Peak davidsonm 03/23/17 08:0454.15 OCDF Split Peak davidsonm 03/23/17 08:0454.30
DIOXIN MANUAL INTEGRATION SUMMARY
TestAmerica Knoxville 180-64125-2
Instrument ID: Analysis Batch Number:D2A 9766
Lab Sample ID: Client Sample ID:
Date Analyzed: Lab File ID:
COMPOUND NAME RETENTION
TIME
MANUAL INTEGRATION
DATEANALYSTREASON
180-64125-3 #20170156 AMENDED COMPOSITE J
180-64125-e-3-a.d03/23/17 03:29 GC Column: RTX-5 ID: 0.32(mm)
2,3,4,7,8-PeCDF Baseline davidsonm 03/23/17 08:2340.34 1,2,3,4,7,8-HxCDF Split Peak davidsonm 03/23/17 08:2344.05 1,2,3,6,7,8-HxCDF Baseline davidsonm 03/23/17 08:2344.18 2,3,4,6,7,8-HxCDF Baseline davidsonm 03/23/17 08:2344.91 1,2,3,4,7,8-HxCDD Baseline davidsonm 03/23/17 08:2345.07 1,2,3,7,8,9-HxCDD Split Peak davidsonm 03/23/17 08:2345.58 1,2,3,7,8,9-HxCDF Baseline davidsonm 03/23/17 08:2345.87 1,2,3,4,6,7,8-HpCDF Baseline davidsonm 03/23/17 08:2348.27 1,2,3,4,6,7,8-HpCDD Split Peak davidsonm 03/23/17 08:2349.95 1,2,3,4,7,8,9-HpCDF Split Peak davidsonm 03/23/17 08:2350.59 OCDD Split Peak davidsonm 03/23/17 08:2354.12
Lab Sample ID: Client Sample ID:
Date Analyzed: Lab File ID:
COMPOUND NAME RETENTION
TIME
MANUAL INTEGRATION
DATEANALYSTREASON
180-64125-4 #20170167 AMENDED COMPOSITE U
180-64125-e-4-a.d03/23/17 04:30 GC Column: RTX-5 ID: 0.32(mm)
1,2,3,7,8,9-HxCDD Split Peak davidsonm 03/23/17 08:2745.58 1,2,3,4,7,8,9-HpCDF Split Peak davidsonm 03/23/17 08:2750.58
REAGENT TRACEABILITY SUMMARY
Lab Name:
SDG No.:
Job No.: 180-64125-2TestAmerica Knoxville
Reagent ID Exp Date Date
Prep Dilutant Used
Reagent Final Volume
Parent Reagent
Reagent ID Volume Added ConcentrationAnalyte
07/31/25 12/12/16 200 mL 10XXDFCL37INP_00001 0.02 mL 37Cl4-2,3,7,8-TCDD 0.2 ng/mL10CSDFCL37CUP_00012 Hexane, Lot 130362 07/31/25 09/28/16 3 mL 10INDFCL37P_00001 0.12 mL 37Cl4-2,3,7,8-TCDD 2000 ng/mL.10XXDFCL37INP_00001 Nonane, Lot SHBH0333V 07/31/25 (Purchased Reagent) 37Cl4-2,3,7,8-TCDD 50 ug/mLCambridge Isotope, Lot ER05211501..10INDFCL37P_00001
10MXDFC13ISP_00006 13C-1,2,3,4,6,7,8-HpCDD 1 ng/mL200 mL 2 mL08/31/22 12/12/1610IDDFC13WRKP_00010 ACETONE, Lot 144642 13C-1,2,3,4,6,7,8-HpCDF 1 ng/mL 13C-1,2,3,4,7,8,9-HpCDF 1 ng/mL 13C-1,2,3,4,7,8-HxCDD 1 ng/mL 13C-1,2,3,4,7,8-HxCDF 1 ng/mL 13C-1,2,3,6,7,8-HxCDD 1 ng/mL 13C-1,2,3,6,7,8-HxCDF 1 ng/mL 13C-1,2,3,7,8,9-HxCDF 1 ng/mL 13C-1,2,3,7,8-PeCDD 1 ng/mL 13C-1,2,3,7,8-PeCDF 1 ng/mL 13C-2,3,4,6,7,8-HxCDF 1 ng/mL 13C-2,3,4,7,8-PeCDF 1 ng/mL 13C-2,3,7,8-TCDD 1 ng/mL 13C-2,3,7,8-TCDF 1 ng/mL 13C-OCDD 2 ng/mL
10XX13COCDFP_00001 0.04 mL 13C-OCDF 2 ng/mL 10/01/25 (Purchased Reagent) 13C-1,2,3,4,6,7,8-HpCDD 100 ng/mLCIL, Lot ER05281501.10MXDFC13ISP_00006
13C-1,2,3,4,6,7,8-HpCDF 100 ng/mL 13C-1,2,3,4,7,8,9-HpCDF 100 ng/mL 13C-1,2,3,4,7,8-HxCDD 100 ng/mL 13C-1,2,3,4,7,8-HxCDF 100 ng/mL 13C-1,2,3,6,7,8-HxCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDF 100 ng/mL 13C-1,2,3,7,8,9-HxCDF 100 ng/mL 13C-1,2,3,7,8-PeCDD 100 ng/mL 13C-1,2,3,7,8-PeCDF 100 ng/mL 13C-2,3,4,6,7,8-HxCDF 100 ng/mL 13C-2,3,4,7,8-PeCDF 100 ng/mL 13C-2,3,7,8-TCDD 100 ng/mL 13C-2,3,7,8-TCDF 100 ng/mL 13C-OCDD 200 ng/mL
08/31/22 10/20/16 5 mL 10INC13OCDFP_00001 1 mL 13C-OCDF 10 ug/mL.10XX13COCDFP_00001 Nonane, Lot SHBH0333V 08/31/22 (Purchased Reagent) 13C-OCDF 50 ug/mLCambridge Isotope, Lot ER080812-01..10INC13OCDFP_00001
61XXDFRSINTP_00001 13C-1,2,3,7,8,9-HxCDD 0.1 ug/mL10 mL 0.2 mL08/01/18 12/12/1610RSDFWRKP_00009 Nonane, Lot SHBH0333V 13C-1,2,3,4-TCDD 0.1 ug/mL
61INDFHXCDRSP_00001 13C-1,2,3,7,8,9-HxCDD 5 ug/mL10 mL 1 mL08/01/18 09/13/12.61XXDFRSINTP_00001 Nonane, Lot 596960KV 61INDFTCDDRSP_00001 1 mL 13C-1,2,3,4-TCDD 5 ug/mL
08/01/18 (Purchased Reagent) 13C-1,2,3,7,8,9-HxCDD 50 ug/mLCambridge Isotope, Lot ER082508-01..61INDFHXCDRSP_00001 06/01/20 (Purchased Reagent) 13C-1,2,3,4-TCDD 50 ug/mLCambridge Isotope, Lot ER060710-01..61INDFTCDDRSP_00001
10XXDFNATP_00004 1,2,3,4,6,7,8-HpCDD 1 ng/mL100 mL 0.5 mL11/30/22 12/12/1610SPDFNATSPKP_00008 ACETONE, Lot 144642 1,2,3,4,6,7,8-HpCDF 1 ng/mL 1,2,3,4,7,8,9-HpCDF 1 ng/mL 1,2,3,4,7,8-HxCDD 1 ng/mL
SDG No.:
Job No.: 180-64125-2TestAmerica Knoxville
Reagent ID Exp Date Date
Prep Dilutant Used
Reagent Final Volume
Parent Reagent
Reagent ID Volume Added ConcentrationAnalyte
1,2,3,4,7,8-HxCDF 1 ng/mL 1,2,3,6,7,8-HxCDD 1 ng/mL 1,2,3,6,7,8-HxCDF 1 ng/mL 1,2,3,7,8,9-HxCDD 1 ng/mL 1,2,3,7,8,9-HxCDF 1 ng/mL 1,2,3,7,8-PeCDD 1 ng/mL 1,2,3,7,8-PeCDF 1 ng/mL 2,3,4,6,7,8-HxCDF 1 ng/mL 2,3,4,7,8-PeCDF 1 ng/mL 2,3,7,8-TCDD 0.2 ng/mL 2,3,7,8-TCDF 0.2 ng/mL OCDD 2 ng/mL OCDF 2 ng/mL
10MXDFNATP_00001 1,2,3,4,6,7,8-HpCDD 200 ng/mL3 mL 0.3 mL11/30/22 10/21/16.10XXDFNATP_00004 Nonane, Lot SHBH0333V 1,2,3,4,6,7,8-HpCDF 200 ng/mL 1,2,3,4,7,8,9-HpCDF 200 ng/mL 1,2,3,4,7,8-HxCDD 200 ng/mL 1,2,3,4,7,8-HxCDF 200 ng/mL 1,2,3,6,7,8-HxCDD 200 ng/mL 1,2,3,6,7,8-HxCDF 200 ng/mL 1,2,3,7,8,9-HxCDD 200 ng/mL 1,2,3,7,8,9-HxCDF 200 ng/mL 1,2,3,7,8-PeCDD 200 ng/mL 1,2,3,7,8-PeCDF 200 ng/mL 2,3,4,6,7,8-HxCDF 200 ng/mL 2,3,4,7,8-PeCDF 200 ng/mL 2,3,7,8-TCDD 40 ng/mL 2,3,7,8-TCDF 40 ng/mL OCDD 400 ng/mL OCDF 400 ng/mL
11/30/22 (Purchased Reagent) 1,2,3,4,6,7,8-HpCDD 2000 ng/mLCambridge Isotope, Lot ER111212-01..10MXDFNATP_00001 1,2,3,4,6,7,8-HpCDF 2000 ng/mL 1,2,3,4,7,8,9-HpCDF 2000 ng/mL 1,2,3,4,7,8-HxCDD 2000 ng/mL 1,2,3,4,7,8-HxCDF 2000 ng/mL 1,2,3,6,7,8-HxCDD 2000 ng/mL 1,2,3,6,7,8-HxCDF 2000 ng/mL 1,2,3,7,8,9-HxCDD 2000 ng/mL 1,2,3,7,8,9-HxCDF 2000 ng/mL 1,2,3,7,8-PeCDD 2000 ng/mL 1,2,3,7,8-PeCDF 2000 ng/mL 2,3,4,6,7,8-HxCDF 2000 ng/mL 2,3,4,7,8-PeCDF 2000 ng/mL 2,3,7,8-TCDD 400 ng/mL 2,3,7,8-TCDF 400 ng/mL OCDD 4000 ng/mL OCDF 4000 ng/mL
SDG No.:
Job No.: 180-64125-2TestAmerica Knoxville
Reagent ID Exp Date Date
Prep Dilutant Used
Reagent Final Volume
Parent Reagent
Reagent ID Volume Added ConcentrationAnalyte
61CV1613S_00001 1,2,3,4,6,7,8-HpCDD 50 ng/mL1 mL 1000 uL04/01/20 04/08/1561CV1613OS_00005 Nonane, Lot 13CS30114 1,2,3,4,6,7,8-HpCDF 50 ng/mL 1,2,3,4,7,8,9-HpCDF 50 ng/mL 1,2,3,4,7,8-HxCDD 50 ng/mL 1,2,3,4,7,8-HxCDF 50 ng/mL 1,2,3,6,7,8-HxCDD 50 ng/mL 1,2,3,6,7,8-HxCDF 50 ng/mL 1,2,3,7,8,9-HxCDD 50 ng/mL 1,2,3,7,8,9-HxCDF 50 ng/mL 1,2,3,7,8-PeCDD 50 ng/mL 1,2,3,7,8-PeCDF 50 ng/mL 13C-1,2,3,4,6,7,8-HpCDD 100 ng/mL 13C-1,2,3,4,6,7,8-HpCDF 100 ng/mL 13C-1,2,3,4,7,8,9-HpCDF 100 ng/mL 13C-1,2,3,4,7,8-HxCDD 100 ng/mL 13C-1,2,3,4,7,8-HxCDF 100 ng/mL 13C-1,2,3,6,7,8-HxCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDF 100 ng/mL 13C-1,2,3,7,8,9-HxCDF 100 ng/mL 13C-1,2,3,7,8-PeCDD 100 ng/mL 13C-1,2,3,7,8-PeCDF 100 ng/mL 13C-2,3,4,6,7,8-HxCDF 100 ng/mL 13C-2,3,4,7,8-PeCDF 100 ng/mL 13C-2,3,7,8-TCDD 100 ng/mL 13C-2,3,7,8-TCDF 100 ng/mL 13C-OCDD 200 ng/mL 2,3,4,6,7,8-HxCDF 50 ng/mL 2,3,4,7,8-PeCDF 50 ng/mL 2,3,7,8-TCDD 10 ng/mL 2,3,7,8-TCDF 10 ng/mL 37Cl4-2,3,7,8-TCDD 10 ng/mL OCDD 100 ng/mL OCDF 100 ng/mL
61XX13COCDFP_00001 20 uL 13C-OCDF 200 ng/mL 04/01/20 (Purchased Reagent) 1,2,3,4,6,7,8-HpCDD 50 ng/mLWELLINGTON, Lot 13CS30114.61CV1613S_00001
1,2,3,4,6,7,8-HpCDF 50 ng/mL 1,2,3,4,7,8,9-HpCDF 50 ng/mL 1,2,3,4,7,8-HxCDD 50 ng/mL 1,2,3,4,7,8-HxCDF 50 ng/mL 1,2,3,6,7,8-HxCDD 50 ng/mL 1,2,3,6,7,8-HxCDF 50 ng/mL 1,2,3,7,8,9-HxCDD 50 ng/mL 1,2,3,7,8,9-HxCDF 50 ng/mL 1,2,3,7,8-PeCDD 50 ng/mL 1,2,3,7,8-PeCDF 50 ng/mL 13C-1,2,3,4,6,7,8-HpCDD 100 ng/mL 13C-1,2,3,4,6,7,8-HpCDF 100 ng/mL 13C-1,2,3,4,7,8,9-HpCDF 100 ng/mL
SDG No.:
Job No.: 180-64125-2TestAmerica Knoxville
Reagent ID Exp Date Date
Prep Dilutant Used
Reagent Final Volume
Parent Reagent
Reagent ID Volume Added ConcentrationAnalyte
13C-1,2,3,4,7,8-HxCDD 100 ng/mL 13C-1,2,3,4,7,8-HxCDF 100 ng/mL 13C-1,2,3,6,7,8-HxCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDF 100 ng/mL 13C-1,2,3,7,8,9-HxCDF 100 ng/mL 13C-1,2,3,7,8-PeCDD 100 ng/mL 13C-1,2,3,7,8-PeCDF 100 ng/mL 13C-2,3,4,6,7,8-HxCDF 100 ng/mL 13C-2,3,4,7,8-PeCDF 100 ng/mL 13C-2,3,7,8-TCDD 100 ng/mL 13C-2,3,7,8-TCDF 100 ng/mL 13C-OCDD 200 ng/mL 2,3,4,6,7,8-HxCDF 50 ng/mL 2,3,4,7,8-PeCDF 50 ng/mL 2,3,7,8-TCDD 10 ng/mL 2,3,7,8-TCDF 10 ng/mL 37Cl4-2,3,7,8-TCDD 10 ng/mL OCDD 100 ng/mL OCDF 100 ng/mL
06/01/21 11/10/15 5 mL 61INC13OCDFP_00001 1 mL 13C-OCDF 10 ug/mL.61XX13COCDFP_00001 Nonane, Lot SHBC8566V 06/01/21 (Purchased Reagent) 13C-OCDF 50 ug/mLCerriliant, Lot ER062011-01..61INC13OCDFP_00001
61L11613P_00001 1,2,3,4,6,7,8-HpCDD 2.5 ng/mL0.2 mL 200 uL11/10/16 11/09/1561L11613OP_00001 Nonane, Lot
ER031611-01A
1,2,3,4,6,7,8-HpCDF 2.5 ng/mL 1,2,3,4,7,8,9-HpCDF 2.5 ng/mL 1,2,3,4,7,8-HxCDD 2.5 ng/mL 1,2,3,4,7,8-HxCDF 2.5 ng/mL 1,2,3,6,7,8-HxCDD 2.5 ng/mL 1,2,3,6,7,8-HxCDF 2.5 ng/mL 1,2,3,7,8,9-HxCDD 2.5 ng/mL 1,2,3,7,8,9-HxCDF 2.5 ng/mL 1,2,3,7,8-PeCDD 2.5 ng/mL 1,2,3,7,8-PeCDF 2.5 ng/mL 13C-1,2,3,4,6,7,8-HpCDD 100 ng/mL 13C-1,2,3,4,6,7,8-HpCDF 100 ng/mL 13C-1,2,3,4,7,8,9-HpCDF 100 ng/mL 13C-1,2,3,4,7,8-HxCDD 100 ng/mL 13C-1,2,3,4,7,8-HxCDF 100 ng/mL 13C-1,2,3,4-TCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDF 100 ng/mL 13C-1,2,3,7,8,9-HxCDD 100 ng/mL 13C-1,2,3,7,8,9-HxCDF 100 ng/mL 13C-1,2,3,7,8-PeCDD 100 ng/mL 13C-1,2,3,7,8-PeCDF 100 ng/mL 13C-2,3,4,6,7,8-HxCDF 100 ng/mL 13C-2,3,4,7,8-PeCDF 100 ng/mL 13C-2,3,7,8-TCDD 100 ng/mL
SDG No.:
Job No.: 180-64125-2TestAmerica Knoxville
Reagent ID Exp Date Date
Prep Dilutant Used
Reagent Final Volume
Parent Reagent
Reagent ID Volume Added ConcentrationAnalyte
13C-2,3,7,8-TCDF 100 ng/mL 13C-OCDD 200 ng/mL 2,3,4,6,7,8-HxCDF 2.5 ng/mL 2,3,4,7,8-PeCDF 2.5 ng/mL 2,3,7,8-TCDD 0.5 ng/mL 2,3,7,8-TCDF 0.5 ng/mL 37Cl4-2,3,7,8-TCDD 0.5 ng/mL OCDD 5 ng/mL OCDF 5 ng/mL
61XX13COCDFP_00001 4 uL 13C-OCDF 200 ng/mL 03/01/21 (Purchased Reagent) 1,2,3,4,6,7,8-HpCDD 2.5 ng/mLCERILLIANT, Lot ER031611-01A.61L11613P_00001
1,2,3,4,6,7,8-HpCDF 2.5 ng/mL 1,2,3,4,7,8,9-HpCDF 2.5 ng/mL 1,2,3,4,7,8-HxCDD 2.5 ng/mL 1,2,3,4,7,8-HxCDF 2.5 ng/mL 1,2,3,6,7,8-HxCDD 2.5 ng/mL 1,2,3,6,7,8-HxCDF 2.5 ng/mL 1,2,3,7,8,9-HxCDD 2.5 ng/mL 1,2,3,7,8,9-HxCDF 2.5 ng/mL 1,2,3,7,8-PeCDD 2.5 ng/mL 1,2,3,7,8-PeCDF 2.5 ng/mL 13C-1,2,3,4,6,7,8-HpCDD 100 ng/mL 13C-1,2,3,4,6,7,8-HpCDF 100 ng/mL 13C-1,2,3,4,7,8,9-HpCDF 100 ng/mL 13C-1,2,3,4,7,8-HxCDD 100 ng/mL 13C-1,2,3,4,7,8-HxCDF 100 ng/mL 13C-1,2,3,4-TCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDF 100 ng/mL 13C-1,2,3,7,8,9-HxCDD 100 ng/mL 13C-1,2,3,7,8,9-HxCDF 100 ng/mL 13C-1,2,3,7,8-PeCDD 100 ng/mL 13C-1,2,3,7,8-PeCDF 100 ng/mL 13C-2,3,4,6,7,8-HxCDF 100 ng/mL 13C-2,3,4,7,8-PeCDF 100 ng/mL 13C-2,3,7,8-TCDD 100 ng/mL 13C-2,3,7,8-TCDF 100 ng/mL 13C-OCDD 200 ng/mL 2,3,4,6,7,8-HxCDF 2.5 ng/mL 2,3,4,7,8-PeCDF 2.5 ng/mL 2,3,7,8-TCDD 0.5 ng/mL 2,3,7,8-TCDF 0.5 ng/mL 37Cl4-2,3,7,8-TCDD 0.5 ng/mL OCDD 5 ng/mL OCDF 5 ng/mL
06/01/21 11/10/15 5 mL 61INC13OCDFP_00001 1 mL 13C-OCDF 10 ug/mL.61XX13COCDFP_00001 Nonane, Lot SHBC8566V 06/01/21 (Purchased Reagent) 13C-OCDF 50 ug/mLCerriliant, Lot ER062011-01..61INC13OCDFP_00001
SDG No.:
Job No.: 180-64125-2TestAmerica Knoxville
Reagent ID Exp Date Date
Prep Dilutant Used
Reagent Final Volume
Parent Reagent
Reagent ID Volume Added ConcentrationAnalyte
61L21613P_00001 1,2,3,4,6,7,8-HpCDD 10 ng/mL0.2 mL 200 uL03/01/21 11/09/1561L21613OP_00001 Nonane, Lot
ER031611-01B
1,2,3,4,6,7,8-HpCDF 10 ng/mL 1,2,3,4,7,8,9-HpCDF 10 ng/mL 1,2,3,4,7,8-HxCDD 10 ng/mL 1,2,3,4,7,8-HxCDF 10 ng/mL 1,2,3,6,7,8-HxCDD 10 ng/mL 1,2,3,6,7,8-HxCDF 10 ng/mL 1,2,3,7,8,9-HxCDD 10 ng/mL 1,2,3,7,8,9-HxCDF 10 ng/mL 1,2,3,7,8-PeCDD 10 ng/mL 1,2,3,7,8-PeCDF 10 ng/mL 13C-1,2,3,4,6,7,8-HpCDD 100 ng/mL 13C-1,2,3,4,6,7,8-HpCDF 100 ng/mL 13C-1,2,3,4,7,8,9-HpCDF 100 ng/mL 13C-1,2,3,4,7,8-HxCDD 100 ng/mL 13C-1,2,3,4,7,8-HxCDF 100 ng/mL 13C-1,2,3,4-TCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDF 100 ng/mL 13C-1,2,3,7,8,9-HxCDD 100 ng/mL 13C-1,2,3,7,8,9-HxCDF 100 ng/mL 13C-1,2,3,7,8-PeCDD 100 ng/mL 13C-1,2,3,7,8-PeCDF 100 ng/mL 13C-2,3,4,6,7,8-HxCDF 100 ng/mL 13C-2,3,4,7,8-PeCDF 100 ng/mL 13C-2,3,7,8-TCDD 100 ng/mL 13C-2,3,7,8-TCDF 100 ng/mL 13C-OCDD 200 ng/mL 2,3,4,6,7,8-HxCDF 10 ng/mL 2,3,4,7,8-PeCDF 10 ng/mL 2,3,7,8-TCDD 2 ng/mL 2,3,7,8-TCDF 2 ng/mL 37Cl4-2,3,7,8-TCDD 2 ng/mL OCDD 20 ng/mL OCDF 20 ng/mL
61XX13COCDFP_00001 4 uL 13C-OCDF 200 ng/mL 03/01/21 (Purchased Reagent) 1,2,3,4,6,7,8-HpCDD 10 ng/mLCERILLIANT, Lot ER031611-01B.61L21613P_00001
1,2,3,4,6,7,8-HpCDF 10 ng/mL 1,2,3,4,7,8,9-HpCDF 10 ng/mL 1,2,3,4,7,8-HxCDD 10 ng/mL 1,2,3,4,7,8-HxCDF 10 ng/mL 1,2,3,6,7,8-HxCDD 10 ng/mL 1,2,3,6,7,8-HxCDF 10 ng/mL 1,2,3,7,8,9-HxCDD 10 ng/mL 1,2,3,7,8,9-HxCDF 10 ng/mL 1,2,3,7,8-PeCDD 10 ng/mL 1,2,3,7,8-PeCDF 10 ng/mL
SDG No.:
Job No.: 180-64125-2TestAmerica Knoxville
Reagent ID Exp Date Date
Prep Dilutant Used
Reagent Final Volume
Parent Reagent
Reagent ID Volume Added ConcentrationAnalyte
13C-1,2,3,4,6,7,8-HpCDD 100 ng/mL 13C-1,2,3,4,6,7,8-HpCDF 100 ng/mL 13C-1,2,3,4,7,8,9-HpCDF 100 ng/mL 13C-1,2,3,4,7,8-HxCDD 100 ng/mL 13C-1,2,3,4,7,8-HxCDF 100 ng/mL 13C-1,2,3,4-TCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDF 100 ng/mL 13C-1,2,3,7,8,9-HxCDD 100 ng/mL 13C-1,2,3,7,8,9-HxCDF 100 ng/mL 13C-1,2,3,7,8-PeCDD 100 ng/mL 13C-1,2,3,7,8-PeCDF 100 ng/mL 13C-2,3,4,6,7,8-HxCDF 100 ng/mL 13C-2,3,4,7,8-PeCDF 100 ng/mL 13C-2,3,7,8-TCDD 100 ng/mL 13C-2,3,7,8-TCDF 100 ng/mL 13C-OCDD 200 ng/mL 2,3,4,6,7,8-HxCDF 10 ng/mL 2,3,4,7,8-PeCDF 10 ng/mL 2,3,7,8-TCDD 2 ng/mL 2,3,7,8-TCDF 2 ng/mL 37Cl4-2,3,7,8-TCDD 2 ng/mL OCDD 20 ng/mL OCDF 20 ng/mL
06/01/21 11/10/15 5 mL 61INC13OCDFP_00001 1 mL 13C-OCDF 10 ug/mL.61XX13COCDFP_00001 Nonane, Lot SHBC8566V 06/01/21 (Purchased Reagent) 13C-OCDF 50 ug/mLCerriliant, Lot ER062011-01..61INC13OCDFP_00001
61L31613P_00001 1,2,3,4,6,7,8-HpCDD 50 ng/mL0.2 mL 200 uL03/01/21 11/09/1561L31613OP_00001 Nonane, Lot
ER031611-01C
1,2,3,4,6,7,8-HpCDF 50 ng/mL 1,2,3,4,7,8,9-HpCDF 50 ng/mL 1,2,3,4,7,8-HxCDD 50 ng/mL 1,2,3,4,7,8-HxCDF 50 ng/mL 1,2,3,6,7,8-HxCDD 50 ng/mL 1,2,3,6,7,8-HxCDF 50 ng/mL 1,2,3,7,8,9-HxCDD 50 ng/mL 1,2,3,7,8,9-HxCDF 50 ng/mL 1,2,3,7,8-PeCDD 50 ng/mL 1,2,3,7,8-PeCDF 50 ng/mL 13C-1,2,3,4,6,7,8-HpCDD 100 ng/mL 13C-1,2,3,4,6,7,8-HpCDF 100 ng/mL 13C-1,2,3,4,7,8,9-HpCDF 100 ng/mL 13C-1,2,3,4,7,8-HxCDD 100 ng/mL 13C-1,2,3,4,7,8-HxCDF 100 ng/mL 13C-1,2,3,4-TCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDF 100 ng/mL 13C-1,2,3,7,8,9-HxCDD 100 ng/mL 13C-1,2,3,7,8,9-HxCDF 100 ng/mL
SDG No.:
Job No.: 180-64125-2TestAmerica Knoxville
Reagent ID Exp Date Date
Prep Dilutant Used
Reagent Final Volume
Parent Reagent
Reagent ID Volume Added ConcentrationAnalyte
13C-1,2,3,7,8-PeCDD 100 ng/mL 13C-1,2,3,7,8-PeCDF 100 ng/mL 13C-2,3,4,6,7,8-HxCDF 100 ng/mL 13C-2,3,4,7,8-PeCDF 100 ng/mL 13C-2,3,7,8-TCDD 100 ng/mL 13C-2,3,7,8-TCDF 100 ng/mL 13C-OCDD 200 ng/mL 2,3,4,6,7,8-HxCDF 50 ng/mL 2,3,4,7,8-PeCDF 50 ng/mL 2,3,7,8-TCDD 10 ng/mL 2,3,7,8-TCDF 10 ng/mL 37Cl4-2,3,7,8-TCDD 10 ng/mL OCDD 100 ng/mL OCDF 100 ng/mL
61XX13COCDFP_00001 4 uL 13C-OCDF 200 ng/mL 03/01/21 (Purchased Reagent) 1,2,3,4,6,7,8-HpCDD 50 ng/mLCERILLIANT, Lot ER031611-01C.61L31613P_00001
1,2,3,4,6,7,8-HpCDF 50 ng/mL 1,2,3,4,7,8,9-HpCDF 50 ng/mL 1,2,3,4,7,8-HxCDD 50 ng/mL 1,2,3,4,7,8-HxCDF 50 ng/mL 1,2,3,6,7,8-HxCDD 50 ng/mL 1,2,3,6,7,8-HxCDF 50 ng/mL 1,2,3,7,8,9-HxCDD 50 ng/mL 1,2,3,7,8,9-HxCDF 50 ng/mL 1,2,3,7,8-PeCDD 50 ng/mL 1,2,3,7,8-PeCDF 50 ng/mL 13C-1,2,3,4,6,7,8-HpCDD 100 ng/mL 13C-1,2,3,4,6,7,8-HpCDF 100 ng/mL 13C-1,2,3,4,7,8,9-HpCDF 100 ng/mL 13C-1,2,3,4,7,8-HxCDD 100 ng/mL 13C-1,2,3,4,7,8-HxCDF 100 ng/mL 13C-1,2,3,4-TCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDD 100 ng/mL 13C-1,2,3,6,7,8-HxCDF 100 ng/mL 13C-1,2,3,7,8,9-HxCDD 100 ng/mL 13C-1,2,3,7,8,9-HxCDF…
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it.